Jac Marais

Jac Marais

Jac Marais


Commercial Attorney


  • Specialisation

    • Competition law and regulatory, including transactional advice and compliance.
    • Jac advises a number of large corporate entities in respect of all aspects relating to Competition Law.
    • Jac advises a number of corporate entities on various compliance related aspects including risk management, and represents clients in the High Court and other dispute resolution forums.

  • Bio

    Jac specialises in competition law, commercial litigation, and general regulatory advice. Jac holds qualifications from the University of Stellenbosch, Wits and King’s College, London. He and his team represent local and international clients in numerous high profile matters and their experience spans various sectors, including defence, construction, health, local and municipal government and tax. He presents annual lectures on competition law at the University of Pretoria and is a regular author and speaker on competition law and regulatory matters.


  • Academic

    • BA – University of Stellenbosch | 2004
    • LLB  – University of Stellenbosch | 2006
    • Advanced Certificate in Competition Law – University of Witwatersrand | 2008
    • Postgraduate Diploma in European Competition Law – University of London, King’s College | 2012
    • Was awarded the yearly prize for Top Competition Law Student at the University of Stellenbosch | 2007


  • Qualifications

    • Admitted Attorney | 2009

  • Credentials

    At present Jac is advising and representing:

    • A JSE listed entity in an application for merger approval by the Competition Commission.
    • A multinational corporation with the enquiry into the Special Defence Packages (the “Arms Deal Enquiry”).
    • South African National Accreditation Standards (SANAS) in disputes arising from various aspects arising from the SANAS Act.
    • The South African Revenue Service in litigation arising from losses suffered as a result of a national cheque fraud syndicate.
    • The Norwegian Government in an investigation into the structure and operation of funding in Sub-Saharan Africa.
    • A Pharmaceutical company with a corporate restructure.